cancer clinical trials for Cellular Therapy Support Service - CAR-T (ONC)

10 Cellular Therapy Support Service - CAR-T (ONC) clinical trials found. View a list of all cancer clinical trial types.

• Managed Access Program (MAP) to provide access to CTL019, for acute lymphoblastic leukemia (ALL) or diffuse large B-cell Lymphoma Patients with Out of Specification Leukapheresis Product and/or Manufactured Tisagenlecleucel Out of Specification for Commercial Release

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 1 study evaluating SC291, a hypoimmune allogeneic CD19-directed CAR T cell therapy, in relapsed and/or refractory B-cell malignancies

  Current Status: Not Open

  View links and contact information related to this clinical trial

• Expanded Access Protocol (EAP) For Subjects Receiving Idecabtagene Vicleucel That Is Nonconforming For Commercial Release

  Current Status: Open

  View links and contact information related to this clinical trial

• FT819 in Subjects With B-cell Malignancies

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Axicabtagene Ciloleucel

  Current Status: Not Open

  View links and contact information related to this clinical trial

• Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel

  Current Status: Not Open

  View links and contact information related to this clinical trial

• An Open-Label, Multi-Centre, Phase Ib/II Study Evaluating the Safety and Efficacy of AUTO1, a CAR T Cell Treatment Targeting CD19, in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Protocol (EAP) For Patients Receiving Lisocabtagene Maraleucel That Is Nonconforming For Commercial Release

  Current Status: Open

  View links and contact information related to this clinical trial

• Intermediate-Size Population Expanded Access Program (EAP) for cilta-cel Out-of-Specification (OOS) in Patients with Multiple Myeloma

  Current Status: Open

  View links and contact information related to this clinical trial

• Low Dose Radiation as Bridging Therapy for Lisocabtagene Maraleucel in Relapsed B-Cell Non-Hodgkin Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial